Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terbinafine versus itraconazole for treatment of tinea incognito
IRCT20090515001906N12Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of Terbinafine and itraconazole in Tinea Incognito (TI) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Itching, Skin redness and 1 more. Started Mar 2018; status: completed.
02
Drugs
Terbinafineitraconazole
03
Conditions
Tinea Incognito (TI)
Beyond the preview
Go deeper on IRCT20090515001906N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090515001906N12.